Bridgeway Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-52,783
| Closed | -$272K | – | 1422 |
|
|
2019
Q2 | $272K | Sell |
52,783
-150,500
| -74% | -$776K | ﹤0.01% | 1119 |
|
|
2019
Q1 | $732K | Hold |
203,283
| – | – | 0.01% | 874 |
|
|
2018
Q4 | $1.25M | Buy |
203,283
+40,500
| +25% | +$248K | 0.02% | 652 |
|
|
2018
Q3 | $951K | Hold |
162,783
| – | – | 0.01% | 897 |
|
|
2018
Q2 | $692K | Hold |
162,783
| – | – | 0.01% | 1025 |
|
|
2018
Q1 | $718K | Sell |
162,783
-11,800
| -7% | -$52K | 0.01% | 960 |
|
|
2017
Q4 | $918K | Buy |
174,583
+39,800
| +30% | +$209K | 0.01% | 869 |
|
|
2017
Q3 | $826K | Hold |
134,783
| – | – | 0.01% | 911 |
|
|
2017
Q2 | $974K | Hold |
134,783
| – | – | 0.01% | 837 |
|
|
2017
Q1 | $714K | Buy |
134,783
+47,800
| +55% | +$253K | 0.01% | 936 |
|
|
2016
Q4 | $625K | Hold |
86,983
| – | – | 0.01% | 991 |
|
|
2016
Q3 | $814K | Hold |
86,983
| – | – | 0.01% | 886 |
|
|
2016
Q2 | $550K | Buy |
86,983
+40,000
| +85% | +$253K | 0.01% | 1007 |
|
|
2016
Q1 | $259K | Buy |
+46,983
| New | +$259K | ﹤0.01% | 1247 |
|